Testicular Lymphoma — Clinical Trials

MONDO:00014722 active·1 recruitingLast updated: Mar 20, 2026, 7:45 AM

Testicular Lymphoma has an emerging clinical trial program, driven by procedure and biological therapy.

Recruiting

Active Trials

Procedure1

Biological Therapy1

2 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

Phase 1

Phase 2

Academic/Other2

United States2 trials

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 2Recruiting

Sponsor:Memorial Sloan Kettering Cancer Center

United StatesStarted: Dec 2024Est. completion: Dec 2027Updated: Dec 2025

Phase 1Active, Not Recruiting

Sponsor:City of Hope Medical Center

United StatesStarted: Oct 2013Est. completion: Jun 2026Updated: Oct 2025

Stay informed about clinical trials for Testicular Lymphoma.

Follow this disease to get updates when trials open, close, or change status.

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 20, 2026 at 7:45 AM